ConductScience.org, home

Paper12379721

Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.

Cheng Q and 7 others. Infect Immun, 2002. Cited by 42 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice. Papers, record 12379721. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12379721

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice.
PubMed
Journal
Infect Immun
PubMed
Year
2002
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2021-05-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheng QQi
2Debol SSteven
3Lam HHong
4Eby RRon
5Edwards LLorri
6Matsuka YYury
7Olmsted SBStephen B
8Cleary PPP Patrick

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adhesins, BacterialMajor topic
EndopeptidasesMajor topic
LungMajor topic
Polysaccharides, BacterialMajor topic
Streptococcal InfectionsMajor topic
Streptococcal VaccinesMajor topic
Streptococcus agalactiaeMajor topic
Animals
Blood Bactericidal Activity
Female
Immunization
Mice
Phagocytosis
Serotyping
Vaccines, Conjugate

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AI2006NIAID NIH HHSUnited StatesPubMed

Source PubMed

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19,841,833Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.J Infect Dis1999https://conductscience.org/library/papers/9841833PubMed
29,784,550Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes.Infect Immun1998https://conductscience.org/library/papers/9784550PubMed
310,189,3051997 AAP guidelines for prevention of early-onset group B streptococcal disease.Pediatrics1999https://conductscience.org/library/papers/10189305PubMed
410,225,912Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.Infect Immun1999https://conductscience.org/library/papers/10225912PubMed
514,461,914Current knowledge of type-specific M antigens of group A streptococci.J Immunol1962https://conductscience.org/library/papers/14461914PubMed
610,713,053Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus.J Biol Chem2000https://conductscience.org/library/papers/10713053PubMed
710,809,707Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate.J Bacteriol2000https://conductscience.org/library/papers/10809707PubMed
810,948,119Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a.Infect Immun2000https://conductscience.org/library/papers/10948119PubMed
911,115,709Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.Vaccine2000https://conductscience.org/library/papers/11115709PubMed
1011,254,587Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.Infect Immun2001https://conductscience.org/library/papers/11254587PubMed
1111,953,377The group B streptococcal C5a peptidase is both a specific protease and an invasin.Infect Immun2002https://conductscience.org/library/papers/11953377PubMed
1212,010,974Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding.Infect Immun2002https://conductscience.org/library/papers/12010974PubMed
131,105,186A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newborn.N Engl J Med1976https://conductscience.org/library/papers/1105186PubMed
14768,760Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.N Engl J Med1976https://conductscience.org/library/papers/768760PubMed
1557,196Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease.J Infect Dis1976https://conductscience.org/library/papers/57196PubMed
16344,223Adult mice as a model for early onset group B streptococcal disease.Infect Immun1978https://conductscience.org/library/papers/344223PubMed
173,898,306Group B streptococcal vaccines.Rev Infect Dis1985https://conductscience.org/library/papers/3898306PubMed
183,053,900Group B streptococci inhibit the chemotactic activity of the fifth component of complement.J Immunol1988https://conductscience.org/library/papers/3053900PubMed
192,243,123Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.J Clin Invest1990https://conductscience.org/library/papers/2243123PubMed
201,996,961Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus.Biochem J1991https://conductscience.org/library/papers/1996961PubMed

See all 35 references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42,226,151CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy.BMC Vet Res2026https://conductscience.org/library/papers/42226151PubMed
38,258,026Immunomodulating Enzymes from Streptococcus pyogenes-In Pathogenesis, as Biotechnological Tools, and as Biological Drugs.Microorganisms2024https://conductscience.org/library/papers/38258026PubMed
36,006,736Mast cell-derived factor XIIIA contributes to sexual dimorphic defense against group B streptococcal infections.J Clin Invest2022https://conductscience.org/library/papers/36006736PubMed
35,608,349Virulence Factor Genes and Cytotoxicity of Streptococcus agalactiae Isolated from Bovine Mastitis in Poland.Microbiol Spectr2022https://conductscience.org/library/papers/35608349PubMed
35,055,991Immunogenic Proteins of Group B Streptococcus-Potential Antigens in Immunodiagnostic Assay for GBS Detection.Pathogens2021https://conductscience.org/library/papers/35055991PubMed
34,649,250The Role of Streptococcal Cell-Envelope Proteases in Bacterial Evasion of the Innate Immune System.J Innate Immun2022https://conductscience.org/library/papers/34649250PubMed
30,566,365The Streptococcus agalactiae complement interfering protein combines multiple complement-inhibitory mechanisms by interacting with both C4 and C3 ligands.FASEB J2019https://conductscience.org/library/papers/30566365PubMed
29,995,578Progress toward a group B streptococcal vaccine.Hum Vaccin Immunother2018https://conductscience.org/library/papers/29995578PubMed
26,602,918Adjuvant Immune Enhancement of Subunit Vaccine Encoding pSCPI of Streptococcus iniae in Channel Catfish (Ictalurus punctatus).Int J Mol Sci2015https://conductscience.org/library/papers/26602918PubMed
26,288,735Group B Streptococcus vaccine: state of the art.Ther Adv Vaccines2015https://conductscience.org/library/papers/26288735PubMed
25,492,846Non-proteolytic functions of microbial proteases increase pathological complexity.Proteomics2015https://conductscience.org/library/papers/25492846PubMed
24,421,400Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP.FASEB J2014https://conductscience.org/library/papers/24421400PubMed
23,571,853Genotypes and virulence genes in group B streptococcus isolated in the maternity hospital, Kuwait.Med Princ Pract2013https://conductscience.org/library/papers/23571853PubMed
20,697,258Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Am J Med Sci2010https://conductscience.org/library/papers/20697258PubMed
19,506,013Human serum induces streptococcal c5a peptidase expression.Infect Immun2009https://conductscience.org/library/papers/19506013PubMed
19,401,597Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1.Mol Cell Proteomics2009https://conductscience.org/library/papers/19401597PubMed
19,257,847Understanding the regulation of Group B Streptococcal virulence factors.Future Microbiol2009https://conductscience.org/library/papers/19257847PubMed
16,988,251High-affinity interaction between fibronectin and the group B streptococcal C5a peptidase is unaffected by a naturally occurring four-amino-acid deletion that eliminates peptidase activity.Infect Immun2006https://conductscience.org/library/papers/16988251PubMed
16,299,278
Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.
Infect Immun2005https://conductscience.org/library/papers/16299278PubMed
16,138,188Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells.J Clin Invest2005https://conductscience.org/library/papers/16138188PubMed

See all 22 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12379721

GET https://conductscience.org/api/papers/v1/12379721/references?page=2